Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hoel

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Regulatory Toxicology and Pharmacology : RTP|May 18, 2005
Uses of benchmark dose methodology in quantitative risk assessmentThomas B Starr, Jay I Goodman, David G Hoel
International Journal of Radiation Biology|June 9, 2016
The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiationAntone L Brooks, David G Hoel, R Julian Preston
Journal of the National Cancer Institute|July 7, 1993
Influence of death certificate errors on cancer mortality trendsD G Hoel, E Ron, R Carter, et al.
Health Physics|March 14, 2009
Lung fibrosis and lung cancer incidence in beagle dogs that inhaled 238PuO2 or 239PuO2Dulaney A Wilson, Joseph H Diel, David G Hoel
Cancer Research|December 1, 1991
Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamineJ A Swenberg, D G Hoel, P N Magee
International Journal of Radiation Biology|April 1, 2010
Relative toxicity of (45)Ca beta-particles and (242)Cm alpha-particles following their intravenous injection into mice as radiolabelled FAPNicholas D Priest, David G Hoel, Paul N Brooks
Radiation Research|October 28, 2006
Relative toxicity of chronic irradiation by 45Ca beta particles and 242Cm alpha particles with respect to the production of lung tumors in CBA/Ca miceN D Priest, D G Hoel, P N Brooks
Toxicology and Applied Pharmacology|August 1, 1980
A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chlorideM W Anderson, D G Hoel, N L Kaplan
Radiation Research|November 1, 1987
Altitude, radiation, and mortality from cancer and heart diseaseC R Weinberg, K G Brown, D G Hoel
Cancer Research|September 1, 1986
Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experimentsC J Portier, J C Hedges, D G Hoel
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Regulatory Toxicology and Pharmacology : RTP|May 18, 2005
Uses of benchmark dose methodology in quantitative risk assessmentThomas B Starr, Jay I Goodman, David G Hoel
International Journal of Radiation Biology|June 9, 2016
The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiationAntone L Brooks, David G Hoel, R Julian Preston
Journal of the National Cancer Institute|July 7, 1993
Influence of death certificate errors on cancer mortality trendsD G Hoel, E Ron, R Carter, et al.
Health Physics|March 14, 2009
Lung fibrosis and lung cancer incidence in beagle dogs that inhaled 238PuO2 or 239PuO2Dulaney A Wilson, Joseph H Diel, David G Hoel
Cancer Research|December 1, 1991
Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamineJ A Swenberg, D G Hoel, P N Magee
International Journal of Radiation Biology|April 1, 2010
Relative toxicity of (45)Ca beta-particles and (242)Cm alpha-particles following their intravenous injection into mice as radiolabelled FAPNicholas D Priest, David G Hoel, Paul N Brooks
Radiation Research|October 28, 2006
Relative toxicity of chronic irradiation by 45Ca beta particles and 242Cm alpha particles with respect to the production of lung tumors in CBA/Ca miceN D Priest, D G Hoel, P N Brooks
Toxicology and Applied Pharmacology|August 1, 1980
A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chlorideM W Anderson, D G Hoel, N L Kaplan
Radiation Research|November 1, 1987
Altitude, radiation, and mortality from cancer and heart diseaseC R Weinberg, K G Brown, D G Hoel
Cancer Research|September 1, 1986
Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experimentsC J Portier, J C Hedges, D G Hoel
Pageof 13